Structural and functional characterization of the yeast general transcriptional activator CCR4 by Malvar, Thomas M
University of New Hampshire
University of New Hampshire Scholars' Repository
Doctoral Dissertations Student Scholarship
Winter 1990
Structural and functional characterization of the
yeast general transcriptional activator CCR4
Thomas M. Malvar
University of New Hampshire, Durham
Follow this and additional works at: https://scholars.unh.edu/dissertation
This Dissertation is brought to you for free and open access by the Student Scholarship at University of New Hampshire Scholars' Repository. It has
been accepted for inclusion in Doctoral Dissertations by an authorized administrator of University of New Hampshire Scholars' Repository. For more
information, please contact nicole.hentz@unh.edu.
Recommended Citation




The m ost advanced technology has been used to photograph and 
reproduce this manuscript from the microfilm master. UMI films the 
text directly from the original or copy submitted. Thus, some thesis and 
dissertation copies are in typewriter face, while others may be from any 
type of computer printer.
The quality of this reproduction is dependent upon the quality of the 
copy submitted. Broken or indistinct print, colored or poor quality 
illustrations and photographs, print bleedthrough, substandard margins, 
and improper alignment can adversely affect reproduction.
In the unlikely event that the author did not send UMI a complete 
manuscript and there are missing pages, these will be noted. Also, if 
unauthorized copyright material had to be removed, a note will indicate 
the deletion.
Oversize materials (e.g., maps, drawings, charts) are reproduced by 
sectioning the original, beginning at the upper left-hand corner and 
continuing from left to right in equal sections with small overlaps. Each 
original is also photographed in  one exposure and is included in 
reduced form at the back of the book.
Photographs included in the original manuscript have been reproduced 
xerographically in this copy. Higher quality 6" x 9" black and white 
photographic prints are available for any photographs or illustrations 
appearing in this copy for an additional charge. Contact UMI directly 
to order.
University  M icrofilm s In ternational 
A Bell  & Howell In fo rm at io n  C o m p a n y  
300  N or th  Z e e b  Road. A n n  Arbor.  Ml 4 8 1 0 6 - 1 3 4 6  USA 
3 1 3 /7 6 1 -4 7 0 0  8 0 0  521-0600
Order Number 0119140
Structural and functional characterization of the yeast general 
transcriptional activator CCR4
Malvar, Thomas M., Ph.D.
University of New Hampshire, 1990
U M I
300 N. Zeeb Rd.
Ann Arbor, MI 48106
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF THE 
YEAST GENERAL TRANSCRIPTIONAL ACTIVATOR CCR4
BY
Thomas M. Malvar 
B.S. Syracuse University, 1982
DISSERTATION
Submitted to the University of New Hampshire in Partial 
Fulfillment of the Requirements for the Degree of




This dissertation has been examined and approved.
tation director,Dissert  Clyde Denis 
Professor of Biochemistry
Donald M. Green 
Professor of Biochemistry
'f. ^Z Z T r-
Andrew P. Laudano
Assistant Professor of Biochemistry
>| C(S7!X(U JL^ Aj
Stacia A. Sower 
Associate Professor of Zoology






I would like to thank my family for their continued 
encouragement over my many, many years of "higher education." I 
would also like to thank my dissertation committee members, Dr.
Stacia Sower, Dr. Andy Laudano, Dr. Donald Green, Dr. Robert Zsigray, 
and Dr. Clyde Denis. The financial support, encouragement, and 
guidance provided by Dr. Clyde Denis was appreciated. Many thanks to 
the generosity of Dr. Donald Green for the use of his cabin.
Additionally, I would like to thank Heather Miller for her 
support and friendship. Finally, I am grateful for the friendships of 
the many people I have encountered along the way. My best wishes go 
to Karen Rasmussen, Tim and Gail Blenk, Dave Rizzo, Bob Vallari, 
Steve Mosley and family, Joel Cherry, Lynne Bemis, Dan Chase, Deb 




DEDICATION................................................................................... i i i
ACKNOWLEDGEMENT.................................................................. iv
LIST OF TABLES............................................................................  vii
LIST OF FIGURES.......................................................................... vi i i
ABSTRACT  ...............................................................................  x
I. INTRODUCTION.......................................................................... 1
II. MATERIALS AND METHODS....................................................  1 3
Yeast Strains and Conditions of Growth....................... 1 3
ADH Assays.........................................................................  13
Bacterial and Yeast Transformations............................ 1 3
Plasmid Constructions.......................................................  1 5
DNA Sequencing and Computer Analysis.....................  2 6
Colony Hybridization........................................................... 2 7
Southern Analysis................................................................ 2 8
Northern Analysis................................................................  2 8
III. RESULTS...................................................................................  30
Mapping of CCR4................................................................  3 0
Cloning of CCR4.................................................................. 3 8
v
Sequencing of CCR4...........................................................  3 9
Protein Sequence Similarities..........................................  41
Transcript Identification and
Carbon Source Regulation.................................................  51
Effects of the CRE Alleles on
CC R4 Transcription.............................................................  52
Functional Analysis of CCR4............................................. 5 5






1 Yeast Strains......................................................................... 1 4
2 Effects of ccr4 /cre  Mutations on
ADHII Activity......................................................................  3 5
3 Complementation of the CCR4 Mutation....................... 3 7
4 Effects of Disruptions and Deletions in CCR4




1. Trans-acting regulatory factors controlling
ADH2 transcription...................................................................  6
2. Sequences contained on YCp50-2c, Lambda M7,
and Lambda L4.........................................................................  1 6
3. Sequences contained on p89, pUC18-Bm:Hdt
and YRp7-3.5............................................................................  1 7
4. Construction of pCl :HIS3......................................................... 21
5. Construction of pUC18-Bm:Hd:HIS3...................................... 22
6. Construction of YRp7-3.5:deltaMlul-Hincll.......................  24
7a. Initial mapping of CCR4............................................................  31
7b. Diagram of the left arm of chromosome 1.........................  32
8. Complementation of ccr4 by plasmid construtions.... 3 3
9. Restriction map of CCR4..........................................................  4 0
10. Sequencing strategy for CCR4................................................  4 2
11a. DNA sequence of CCR4............................................................  44
11b. Amino acid sequence of CCR4................................................. 4 5
12. Hydrophobic and hydrophilic regions
of the CCR4 protein................................................................... 4 6
VIII
13a. Alignment of the leucine-rich repeats
found in CCR4............................................................................ 4 9
13b. Consensus sequence for the proteins
containing leucine-rich repeats.............................................. 49
14. The effect of carbon source on CCR4
mRNA levels.............................................................................. 5 2
15. The effect of the CRE alleles on CCR4
mRNA levels.............................................................................. 5 6
16. Disruptions and deletions created in CCR4.......................  58
17. Comparison of the TFIID sequences
between species........................................................................ 7 5
IX
ABSTRACT
STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF THE YEAST 
GENERAL TRANSCRIPTIONAL ACTIVATOR CCR4
BY
Thomas M. Malvar 
University of New Hampshire, December, 1990
Transcription of the glucose-repressible ADH IADH2 locus) in 
Saccharomyces cerevisiae is controlled by two regulatory 
pathways. The general transcriptional factors CCR4. CRE1. and CRE2 
constitute the first pathway while the second pathway is comprised 
of the trans-activators ADR1 and CCR1. Both ADR1 and CCR1 act 
through upstream activation sequences (UAS) found in the 
S'-regulatory region of the ADH2 structual gene. In contrast, the 
action of CCR4. CRE1. and CRE2 is likely to be at sequences near the 
TATAA element of ADH2.
The CCR4 locus was precisely mapped on the left arm of 
chromosome I where it had previously been localized. Plasmid 
constructions bearing sequences from chromosome I in the vicinity 
of CCR4 were tested for their ability to complement a defective 
ccr4 allele. A functional copy of CCR4 was identified and the DNA
sequenced to reveal a  2511-bp open reading frame that predicts a 
protein with an estimated mass of 94.6-kDal. The CCR4 protein 
showed similarity with a  family of proteins containing a 
leucine-rich tandem repeat motif. The repeats are characterized by 
the 24 amino acid repeating sequence P-X-X-o-X-X-L-X-X-L-X-X-L- 
X-L-X-X-N-X-o (where X = any residue; o = aliphatic residues L, I, or 
V) and have been suggested to represent a  domain involved in protein 
binding. Deletion analysis of CCR4 indicates that these repeats are 
required for its proper function. The amino terminus of CCR4 showed 
similarities to a variety of transcription factors including TFIID, 
the TATAA binding factor from humans and Drosophila.
Additional studies indicated that CCR4 mRNA and protein 
levels were not regulated by carbon source availability or the allelic 
state of the CRE genes. These results suggest that the interactions 
observed between CCR4 and the CRE genes occur directly or 
indirectly at a protein level.
The possible role that CCR4 plays in the transcriptional 
regulation of the ADH2 locus based on 1) the sequence similarities 
seen between CCR4 and other proteins and 2) the functional
XI
characterization of deletions and disruptions created within the 
coding sequences of CCR4 are discussed.
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I. INTRODUCTION 
The genome of Saccharomyces cerevisiae encodes four 
NAD+-linked alcohol dehydrogenase (ADH) isozymes. The cytoplasmic 
fermentative isozyme ADH I functions in the NADH linked reduction 
of acetaldehyde to ethanol. In contrast, the cytoplasmic ADH II 
isozyme kinetically favors the reverse reaction in the NAD+ linked 
oxidation of ethanol to acetaldehyde. ADH II thus allows yeast to 
utilize ethanol as a  carbon and energy source when glucose is 
limiting. The abundance of both isozymes is dependent on the 
available carbon source. When yeast are switched from a 
fermentable to a  nonfermentable carbon source ADH 1 transcription 
decreases approximately six-fold (Denis et al., 1983). Transcription 
of ADH2. however, is repressed in cells grown on glucose containing 
medium (Denis et al., 1981) and shows a  500-fold increase upon 
depletion of glucose from the medium. The third isozyme, ADH III, is 
a  nuclear encoded gene which functions in the mitochondria (Young 
and Pilgrim, 1987). The fourth isozyme, ADH IV (Paquin and 
Williamson, 1986), has not been well characterized.
The structural gene for ADH2 has been cloned and sequenced 
(Williamson et al., 1981; Russell et al., 1983). The TATAA element 
for ADH2 resides 160-base-pairs (bp) upstream of the translation 
initiation site (Russel et al., 1983). Two upstream activation 
sequences, UAS1 and UAS2, are required for proper ADH2 regulation 
and are contained within a 50-bp region that is located 111 -bp 
upstream of the TATAA element. UAS1 represents a 22-bp inverted 
repeat while UAS2 is contained within the 25-bp immediately 
upstream of UAS1. Both UAS1 and UAS2 act synergistically in 
response to the transcriptional activator ADR1 (alcohol 
dehydrogenase lepressible; Yu et al., 1989).
The manner in which the glucose repression signal is 
manifested within the cell is not known. However, several 
trans-acting factors affecting the transcriptional state of ADH2 
have been identified (Ciracy, 1975,1977, and 1979; Denis, 1984). 
Denis (1984) proposed that alleles affecting ADH 2 transcription 
fall into two regulatory pathways. The first consists of the positive 
effectors ADR1 and CCR1 (carbon catabolite repressive), and the 
second consisting of the positive effector CCR4. whose action is
controlled by the negative effectors CRE1 and CRE2 (gatabolite 
repressor element)
ADR1 is an essential gene for the derepression of ADH2 
transcription (Denis et al. 1981). Strains harboring an adr1-1 allele, 
characterized by an amber mutation at the eleventh codon, show no 
ADH II activity (Bemis and Denis, 1989). The ADR1 oene has been 
cloned (Denis and Young, 1983) and sequenced (Hartshorne et al., 
1986) and encodes a protein containing two DNA binding zinc fingers. 
ADR1 binds to the upstream activating sequences located in the 
ADH2 promoter under both fermentative and nonfermentative growth 
conditions (Taylor and Young, 1990). Gel retardation studies indicate 
that ADR1 binds predominantly to UAS1; however, optimum binding 
is observed in the presence of both UAS1 and UAS2 (Eisen et al., 
1988). The ADR1 protein also contains a  cAMP dependent protein 
kinase (cAPK) recognition site thought to play a  role in its ability to 
activate transcription (Cherry et al.,1989). Dominant alleles of ADR1 
(AQB1C) which allow for ADH II activity under glucose repression, 
have been identified a s  mutations which purportedly disturb the 
cAPK phosphorylation of ADR1 (Cherry et al., 1989; Denis and Gallo,
1986). The CCR1 gene identified by Ciriacy (1977) is allelic to SNF1 
(Denis, 1984) and codes for a protein kinase required in the 
regulation of several enzymes under glucose repression (Carlson and 
Celenza, 1986). Genetic evidence indicates that CCR1 acts through or 
in conjunction with ADR1 (Denis, 1984) in the regulation of ADH2 
transcription. More recent findings indicate that CCR1 acts through 
factors independent of ADR1 (D. Audino, pers. comm.).
The negative regulatory elements CRE1 and CRE2 were 
identified as mutations which allow for the escape of ADH2 from 
glucose repression as determined by the ability of cells to grow in 
the presence of the respiratory inhibitor antimycin A (Denis, 1984).
The CCR4 allele was identified by mutations which render strains 
containing the crel or cre2 alleles sensitive to antimycin A.
Mutations in these alleles were shown to effect ADH2 at the 
transcriptional level (Denis,1984; Denis and Malvar, 1990). Northern 
analysis identified ADH2 specific mRNA in crel carrying strains 
under glucose repression; a condition when no ADH2 message is 
normally seen. Mutations in CCR4 were found to suppress the 
cre-induced ADH2 mRNA levels observed under repressed conditions
(Denis and Malvar, 1990).
CRE2 is allelic to SPT6 and SSN20 (Denis and Malvar, 1990; 
Clark- Adams and Winston, 1987; Neigebom et al., 1987) while CRE1 
was shown to be allelic to SPT1Q (Denis and Malvar, 1990). The SPT 
(suppressor of TY) genes were originally identified as mutations 
which overcome the effects of delta insertions at the his4-912delta 
locus (Clark-Adams and Winston, 1987; Winston et al., 1984). Delta 
sequences represent the approximately 300-bp terminal repeat of 
the yeast retrotransposon TY. Delta sequences are often left behind 
following transposition of a  TY element into and out of a 
chromosomal location. The sites of action and allelisms of the 
various trans-acting regulatory factors controlling ADH2 
transcription is shown in Figure 1. The identity of several members 
of the SPT gene family has been determined. The SPT11 and SPT12 
genes encode histone proteins (Clark-Adams et al., 1988), SPT13 is 
allelic to the transcriptional regulatory factor GAL11. required for 
galactose gene expression, and SPT15 is the yeast "TATAA"- binding 
factor, TFIID (Eisenman et al., 1989). The SSN20 allele was 
identified by mutations which overcome a suc2 phenotype caused by
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defects in the SNF2 allele, itself a  general transcriptional effector 
(Neigeborn et al., 1987). The SUC2 gene encodes the enzyme 
invertase that acts in the metabolism of sucrose. The identification 
of members of the SPT gene family as components of transcriptional 
regulation and chromatin structure suggests that SPT6 (CRE2) and 
SPT1Q (CRE1) act in a  similar capacity.
Both CCR4 and the CRE alleles are pleiotropic in their effects 
on cellular processes. Mutations in CCR4 affect other 
nonfermentative genes (Denis, 1984) and show a  temperature 
sensitive phenotype following growth on nonfermentative medium 
(Denis and Malvar, 1990). Mutations in both CRE alleles affect cell 
morphology resulting in an elongated cell shape (Denis, 1984). In the 
case of a  crel allele, a  mutation in CCR4 was shown to suppress the 
aberrant cell morphology (Denis and Malvar, 1990). Additionally, 
mutations in CRE2 result in a temperature sensitive phenotype that 
cannot be suppressed by a  ccr4 allele (Denis and Malvar, 1990).
The effects of CCR4 and the CRE alleles occur through 
sequences near the TATAA element of ADH2 (Denis and Malvar, 
1990). Strains harboring deletions, disruptions, or displacements of
sequences upstream of the ADH2 TATAA element continue to show 
elevated ADH II activity under repressed conditions in a crel or cre2 
background when compared to controls (Denis and Malvar, 1990). 
Mutations in CCR4 were able to suppress the cre-induced effects in 
these strains. Additionally, mutations in CCR4 suppress the effects 
that crel (sptlQ) or cre2 (spt61 have in overcoming delta insertions 
in the his4-912de(ta promoter (Denis and Malvar, 1990). The finding 
that mutations in SSN2Q (CRE21 are able to express SUC2 in a  suc2 
allele created by deletions of sequences 5' to the TATAA element 
indicates that SSN2Q also acts near TATAA sequences in its control 
of SUC2 (Neigeborn et al., 1987).
Deletion of SPT6 (CRE2. SSN20) is lethal in haploid yeast 
strains (Clark-Adams and Winston, 1987), a  result consistent with 
the temperature sensitive phenotype of spt6 alleles. The genes for 
SPT6 and SPT10 have been cloned and sequenced (Swanson et al, 
1990; G. Natsoulis, personal communication). SPT6 codes for a  
nuclear protein that has an estimated mass of 170-kDal and which 
contains a highly acidic amino terminus (Swanson et al., 1990). Both 
increasing and decreasing the dosage of SPT6 results in the
suppression of a  his4-912delta allele and deletions in the regulatory 
5' region of the SUC2 locus (Clark-Adams and Winston, 1987; 
Neigeborn et al., 1987). Proteins containing a  high density of acidic 
residues have been implicated in chromatin binding (Earnshaw,
1987). The possibilty that SPT6 may play a  role in chromatin 
structure around the TATAA element is also supported by the 
observation that varying the dosage of histone proteins has similar 
effects on his4-912delta as that seen for SPT6 (Clark-Adams et al.,
1988).
The action of CCR4 and the CRE alleles on multiple loci 
suggests they act in a  general manner in the regulation of 
transcription. Recent work on the initiation of transcription has 
identified multiple factors that constitute components of the 
transcriptional machinery (for a  review see Lillie and Green, 1989). 
In addition to the multi-subunit RNA polymerase II, several 
heterogeneous fractions from cell extracts have been identified as 
containing factors required for transcription. These include TFIIA, 
TFIIB, TFIID, TFIIE, and TFIIF. Recently the gene coding for the 
protein factor TFIID has been cloned and sequenced fom human,
Drosophila, and yeast (Kao et al., 1990; Hoey et al., 1990; Cavallini 
et al., 1989). The TFIID protein is required for the first step in the 
initiation of transcription and acts by binding to the TATAA element 
(Lillie and Green, 1989). TFIID is also thought to provide contacts 
between the transcriptional machinery and transcriptional 
activators which bind DNA activation sites that lie upstream of the 
TATAA element (for a  review see Ptashne and Gann, 1990; Lewin, 
1990). Additionally, a  heteromeric protein, RAP30/70, has been 
identified as a  component of the TFIIF fraction (Burton et al., 1988).
The protein products of CCR4 and the CRE alleles may 
represent components of the transcriptional fractions discussed 
above. Their action at a variety of loci support their general role in 
transcriptional regulation. Additionally, their site of action appears 
to be through sequences that lie near the TATAA element. The 
objective of this study is to better understand the role that CCR4 
plays in the regulation of transcription. As a requisite for 
addressing this objective, the gene encoding CCR4 had to be cloned. 
CCR4 w as precisely mapped on chromosome I which allowed the use 
of physically defined segments of chromosome I to be used to
10
identify the location of CCR4 by complementation of a  ccr4 defect.
The cloning of CCR4 would allow for addressing several 
questions: 1) What is the DNA sequence of the open reading frame 
that represents the CCR4 gene? 2) Based on the DNA sequence what 
is the predicted size and composition of the resulting polypeptide?
3) Does analysis of the protein sequence reveal any homologies to 
known proteins of known function? 4) If so, does this suggest a 
role(s) that CCR4 plays in the regulation of transcription?
To address these questions, plasmids that contain CCR4 
sequences as determined by complementation studies were used to 
determine the DNA sequence of CCR4. The predicted amino acid 
sequence was searched against data bases containing the sequences 
of known genes and any similarities found were analyzed for clues 
as to the possible function of CRR4. Studies were also performed to 
assess possible factors that regulate CCR4 at a transcriptional level 
including that of carbon source and the allelic state of the CRE 
genes. In order to determine regions of functional importance in the 
CCR4 protein, a series of disruptions and deletions in the coding 
region of CCR4 were constructed. These constructions were then
11
tested for phenotypes that they impart in various genetic 
backgrounds.
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II. MATERIALS AND METHODS 
Yeast strains and conditions of growth
Yeast strains are listed in Table 1 . Yeast cultures were grown 
in YEP medium (2% Bacto-Peptone, 1% yeast extract, 20mg/liter 
each of adenine and uracil) supplemented to a final concentration of 
either 8% glucose (YEP-GIc) or 3% ethanol (YEP-Et). Yd plates 
contained YEP medium supplemented to 2% glucose and 2.5% agar. 
YD8% and YET plates contained YEP-GIc or Yep-Et medium, 
respectively, and 2.5% agar. GLY plates contain YEP medium 
supplemented to 3% glycerol and 2.5% agar. Where indicated, the 
respiratory inhibitor antimycin A (Sigma Chemical Co.) was added to 
a concentration of 0.6 ug/l. Minimal plates lacking tryptophan, 
histidine, leucine, or uracil for selection purposes were used where 
indicated (Wiliamson etal., 1981).
ADH Assays
ADH II enzyme activities were assayed as previously described 
(Denis and Young, 1983). Activities are reported as  milliUnits of ADH 
activity per milligram total protein.
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Tab le  1 : Veast s tra in s
S t ra in Genotype
8 2 - 2 b MATo odh 1-1 ere  1-1 h is3  leu2 t rp  1 u ra l
8 5 - 1c MATa adh 1 -1 ccr4-10:HIS3 trp  1 Ieu2
2 9 2 - 6 a MATe adh 1 -1 adel  h is3  SP07:LEU2 t r p !
3 !7 -5 b MATo adh 1-1 c c r 4 - 1 0  leu2  ura3
3 4 8 - 13a MAT a adh 1 -1 c c r 4 - 10 ura3  trp  1
348-26C MATo adh 1-1 c c r 4 - 1 0  h is3  leu2 t r p l  ura3
3 5 0 - 19a MATo adh 1 -1 c c r 4 - 1 0  t r p l  ura3
3 5 0 - 19b MATa adh 1-1 CCR4:TRP1 his3  leu2 ura  3
3 5 0 - 19c MATo adh 1-1 c c r 4 - 1 0  t r p l  ura3
3 5 0 - 19d MATa adh 1-1 CCR4:TRP1 his3 lue2 ura3
5 0 0 - 1 6 MATa a d h l - 1  adh3 a d r l - 1  h i s 4 t r p 1  u ra l
5 0 0 - 1 6 - 1 MATa adh 1 -1 adh3 a d r l - 1  ere  1-1 h i s 4  t r p l  u ra l
5 0 0 - 1 6 - 1 4 MATa adh 1-1 adh3 a d r l - 1  cre2-1  h i s 4 t r p 1  ura3
6 1 2 - I d MATe adh 1-1 h is3  leu2 t r p l  ura3
FW712-1d MATo adh 1- 1:URA3 h i s4 -912de1 ta  u r a 3 - 5 2
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Bacterial and Yeast Transformation
Bacterial transformations were performed using competent DH5o or 
RR1 cells (purchased from BRL, Gaithersburg, MD). Transformations 
were conducted as recomended by the manufacturer.
Yeast transformations were performed using the lithium 
acetate (LIAc) procedure (Ito et at., 1983).
Plasmid Constructions
DNA polymerase, DNA ligase, and restriction enzymes were 
purchased from New England Biolabs (Beverly, MA). Conditions for 
DNA fill in, ligation, and restriction reactions were a s  recomended 
by the manufacturer. DNA fragments were resolved on 0.7% agarose 
gels and visualized under UV light after staining with ethidium 
bromide (Maniatis et al.). When required, DNA fragments were 
isolated by excision from agarose gels a s  described in Appendix A.
Constructions lambda L4, Lambda M7, YCp50-2c, and p89 were 
gifts of D. Kaback (see Figures 2, 3a, and 3b). Lambda L4 contains 
approximately 17-kilobases (kb) of chromosome I DNA in the lambda 
1059 cloning vector. Lambda M7 contains approximately 18.5-kb of 
chromosome I DNA in the lambda 1059 cloning vector. YCp50-2c
15
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Figure 2 :  Sequences conta ined on YCp50-2c, Lambda M7, 
and Lambda L4.
The le f t  a rm  of chromosome I is  shown along w i th  a 
r ep re sen ta t ion  of sequences  conta ined on YCp50-2c, Lambda 
M7, and Lambda L4 (■■). The r e s t r i c t i o n  s i t e  designa t ions  
are  B = BamHI and H = Hindi 11.
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Figure 3 : Sequences contained on p89, pUC18-Bm:Hd, and YRp7-3.5.
a .  Detailed r e s t r i c t i o n  map of chromosome I in the  pred ic ted  a rea  
of CCR4 is  shown. The posi t ion  of a portion of Lambda L4 ( ■ ■  ) is 
shown as a re ference .  Sequences conta ined in the c o n s t ru c t io ns  p89, 
pUC18-Bm:Hd, and YRp7-3.5 e re  shown as open rec tan g le s  ( l. _ . i ). 
The r e s t r i c t i o n  s i t e  designat ions  are  Bm = BamHI, Bg = Bglll, E = 
EcoRI, He = H ind i ,  and Hd = Hindi 11
b. Scaled re p re se n ta t io n  of p89, pUC18-Bm:Hd, and YRp7-3.5. The 
co n s t ru c t io n  p89 has the  1.4-kb H indi  f ragm en t  cloned into  the 
EcoRV s i t e  of the  v e c to r  pBS-KS and was  a g i f t  of D. Kaback. The 
v e c to r  pUC1B-Bm:Hd w a s  cons t ruc ted  by in se r t ion  of th e  1.5-kb 
BamHI to Hindi 11 f ragm en t  into the  polylinker  region of pUC18. 
YRp7-3.5 w as  c o n s t ru c ted  by in se r t ing  the  3 .5-kb Bglll f ragm ent  
in to  the  BamHI s i t e  of the  yeas t  express ion  v e c to r  YRp7. R es t r ic t io n  
s i t e s  a re  shown only fo r  those  sequences derived from chromosome I. 
Designat ions are  : Ampicil lin  (AMP) = ( ■ ) ,  T e t racy c l in e  (Tc) = ( HD), 
TRP 1 (yeas t )  = (E23), v e c to r  sequences = ( M ) ,  and sequences  from 
chromosome I = ( □ ) .
17
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contains the yeast URA3 gene as well a s  approximately 12-kb of 
chromosome I DNA. A 1.4-kb Hindi fragment cloned into the EcoRV 
site of pBS-KS gives the clone p89 (see Figure 3b). Plasmid pHIS3 
contains a  1.7-kb BamHI fragment of the yeast HIS3 gene cloned into 
the polylinker region of pl)C18 and was a  gift from M. Wigler.
YRp7-3.5+ was contructed by subcloning the 3.5-kb Bglll 
fragment isolated from lambda L4 into the BamHI site of the YRp7 
vector (see Figures 3a and 3b). YRp7-3.5- contains the same 3.5-kb 
Bglll fragment in the opposite orientation. The YRp7 vector also 
contains the yeast TRP1 gene. The clone pC1 was isolated from a 
yeast YEP13 genomic library (Nasmyth and Reed, 1981; see Figure 9). 
The library was constructed by cloning a  size fractionated Sau3AI 
limited digestion of yeast chromosomal DNA into the BamHI site of 
the YEP13 vector. Clone pC1 was identified by colony hybridization 
(see below) using the 1.5-kb BamHI to Hindlll fragment isolated 
from YRp7-3.5 as a  probe. The pUC18-Bm:Hd clone was constructed 
by insertion of the 1.5-kb BamHI-Hindlll fragment isolated from 
YRp7-3.5+ into the polylinker of pl)C18 (Figures 3a and 3b). Plasmid 
pM-11.7 represents the 11.7-kb BamHI fragment subcloned from
19
lambda M7 into the vector YRp7 (see Figure 8). Plasmid pL-6.5 
represents the 6.5-kb Hindi 11 fragment subcloned from lambda L4 
into the vector YRp7 (see Figure 8)
Constructions of the disruption and deletions made in CCR4 
were conducted as described below. The plasmid pC1 :HIS3 was made 
by digestion of pC1 at the unique BamHI site within CCR4 and 
insertion of the 17-kb BamHI fragment of HIS3 isolated from pHIS3 
(CCR4:1-668; see Figure 4). This construction represents a 
disruption in the 3' end of CCR4 at base pair (bp) 2004. The plasmid 
pUC18-Bm:Hd:HIS3 was constructed by replacing the 368-bp Hindi 
fragment in pl)C18-Bm:Hd with a  filled in 1.7-kb BamHI fragment of 
the yeast HIS3 gene isolated from the plasmid pHIS3 (CCR4:1 -392; 
see Figure 5). This construction disrupts CCR4 at bp 1175 leaving 
the truncated protein with two of the five leucine rich repeats 
intact. An inframe deletion removing 397-bp from the middle of the 
CCR4 gene was constructed by restricting p(JC18-Bm:Hd with both 
Mlul and Hindi, filling in the Mlul 5' overhang, and religating the 
ends (see Figure 6). The BamHI to.Smal fragment containing the 
deletion w as then isolated from the resulting construction and used
2 0
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Figure 4  : Construct ion  of pCI:HIS3.
CCR4 w a s  d is rup ted  in pCI a t  the  in ternal  BamHI s i t e  by 
inse r t ion  of the y e a s t  HIS3 gene i so la ted  from pHIS3. 
R e s t r ic t io n  s i t e s  in the  vec tor  pCI a re  shown only for  those  
sequences  derived f rom chromosome I. Sequence des ignat ions  
are: ampic i l in  gene ( ■ ) ,  HIS3 gene (HUD), v e c to r  sequences  
( W ) ,  y e a s t  LEU2 gene ( H ) ,  and sequences from 
chromosome I ( □ ) .
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Figure 5 : Construction of pUC18-0m:Hd:HIS3
CCR4 was  d is rup ted  by rep lacm ent  of the  internal  H ind i  
f rag m en t  (bp 1 1 7 5 -1 5 4 3 )  w i t h  the y e a s t  HIS3 gene i so la te d  from 
pHIS3. The p la sm id  pHIS3 w a s  r e s t r i c t e d  w i th  BamHI , t h e  H1S3 
gene was i s o la t e d ,a n d  the 5'  overhang f i l l e d  in. The p lasmid  
pUC18-Bm:Hd w a s  r e s t r i c t e d  with  H ind i  and the HIS3 gene 
in se r te d .  R e s t r ic t io n  s i t e s  f o r  pUC18-Bm:Hd are show n only for  
th o s e  sequences derived f ro m  chromosome I. Sequence 
designa t ions  a re  : ampicil in gene gene (mil) ,  vec tor
sequences  ( E 2 ) ,  and sequences  from chromosome I ( d ) .
2 2




1. R estrict with BamHI
2. Isolate HIS3 gene Hindi
Figure 6 : Construct ion  of YRp7-3.5:deltaMlul-Hincll
The v ec to r  pUCIB-Bm.Hd w as  r e s t r i c t e d  w i th  both Mlul and 
H in d i ,  the 5' overhang of the  Mlul s i t e  w as  f i l led  in, and the 
blunt  ends l ig a ted  to g e th e r  to make pUC18-deltaMlu:Hinc. This  
co ns t ru c t io n  g ives  an Infram e de le t ion  in CCR4 which removes 
all but  one full copy of the  leucine r ich  repea t  region. In o rder  to 
co n s t ru c t  a y e a s t  vec to r  containing the  Inframe dele tion,  the  
BamHI to Smal f ragm ent  from pUC18-deltaMlu:Hinc was 
i so la te d  and used to rep lace  the analogous BamHI to Smal 
f rag m en t  from VRp7-3.5. The new c o n s t ru c t  w a s  designated  
YRp7-3.5:deltaMlul-H1ncll.  R es t r ic t ion  s i t e s  a re  shown only fo r  
those  sequences  derived from chromosome I.
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2. R estrict YRp7-3.5 with BamHI 
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to replace the analogousl .5-kb BamHI to Smal fragment in the vector 
YRp7-3.5+. The new construction was designated YRp7-3.5:delta 
Miul-Hincll (CCR4:1-382/514-837; see Figure 5) and removes all but 
one full repeat of the leucine rich region (residues 383 - 514).
DNA Sequencing and Computer Analysis
Double stranded template preparation and subsequent alkali 
denaturation were conducted as described by Wang et al. (Appendix 
B). The sequence of CCR4 was determined by using Sequenase 
purchased from USB, Cleveland, OH. The sequence reactions were 
conducted as described by the manufacturer. Synthetic 
oligonucleotide primers were purchased from either Operon 
Technologies, Alameda, CA or Promega Biotec, Madison, Wl. The 
35s-Deoxyadenosine 5'-[0 -thio]triphosphate was obtained from New 
England Nuclear, Boston, MA. The deduced amino acid sequence was 
searched against the National Biomedical Research Foundation 
database for homologies using the program FASTP (Lipman and 
Pearson, 1985). A linear hydrophilicity plot of the CCR4 protein was 
performed using the algorithm of Kyte and Doolittle in the DNA 
Stryder sequence analysis program.
Colony Hybridization
Approximately 250 bacterial colonies per plate were grown 
overnight on AMP plates. Duplicates were made of the colonies by 
replica plating and one set was transferred onto Whatman 541 filter 
paper. The filters were then washed at room temperature in 0.5 M 
NaOH for ten minutes followed by three ten minute w ashes in 2X SCP 
(2 M NaCI, 0.75 M Na2HP04, 10 mM EDTA). The DNA w as fixed by 
baking the filters at 80 0 C under vacuum for two hours.
The desired DNA probe was isolated from an agarose gel 
(Appendix A) and labeled using a random primed DNA labeling kit 
following the manufacturers protocol (USB, Cleveland, OH).
Prehybridization was performed for five minutes by boiling a 
solution of 0.6 ml 10% sarkosyl, 0.3 ml 2 mg/ml sheared salmon 
sperm DNA, and 3 ml H20  for ten minutes, cooling for five minutes on 
ice, and addition of 1.8 ml of 20X SCP. The solution w as then added 
to a  plastic hybridization bag containing the filter. Hybridization 
was performed as described above with the exception of the addition 
of the labeled DNA probe to the prehybridization solution prior to 
boiling. Hybridization was carried out overnight at 65 0 C. The filters
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were washed at room temperature twice in 2X SCP, 1% SDS for 
fifteen minutes, twice with 2X SCP for fifteen minutes, and once for 
fifteen minutes in 0.4% SCP. The filters were then blotted dry, 
wraped in plastic film, and exposed on Kodak X-OMAT diagnostic 
film.
Southern Analysis
Yeast chromosomal DNA was digested with restriction 
endonucleases, run on an agarose gel, stained in ethidium bromide, 
and photographed. The gel w as then washed at room temperature 
twice for eight minutes in 0.25 M HCI, twice for fifteen minutes in 1 
M NaCI, 0.5 M NaOH solution, and once for fourty-five minutes in a 
solution of 1 M Tris pH 7.0, 0.6 M NaCI. The DNA was transferred by 
blotting onto nitrocellulose (Millipore Corp., Bedford, MA) for two 
hours and then baked under vacuum at 80 ° C for two hours. DNA 
probe preparation and hybridization were conducted as  described 
above.
Northern Analysis
The preparation of total yeast RNA has been described (Denis, 
Ferguson, and Young, 1983). The appropriate labeled DNA probe was
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prepared as described above. Gene Screen hybridization transfer 
membrane was supplied by New England Nuclear, Boston, MA. 
Northern analysis was performed by the glyoxal gel method as 
described in the manufacturer’s instruction manual. Densitometric 
analysis of ADH2 mRNA, CCR4 mRNA, and rRNA was conducted using 
an E-C- 610 densitometer. The levels of ADH2 and CCR4 message 
were normalized to the level of rRNA loaded onto the gel as 




Initial mapping data for CCR4 (Denis, personal communication) 
showed linkage to ADE1 on chromosome I. The segregation ratios 
between CCR4. ADE1. CDC24. and the centromere linked TRP1 
(chromosome IV) placed CCR4 near the MAK16 locus on the left arm 
of chromosome I (see Figure 7a). Several plasmid constructions 
containing sequences from the predicted location of CCR4 on 
chromosome I were tested for their ability to complement ccr4 
allele. Strain 348-26c (ccr4) was transformed with either the 
YCp50-2c or pM-11.7 plasmid and assessed for growth at 37°C on 
nonfermentative media (see Figure 8). None of the plasmid 
constructions were found to complement the ccr4 allele contained in 
strain 348-26C.
Since the cM map distance may not always quantitatively 
correlate with the physical distance between loci, a  more precise 
mapping of CCR4 was required in order to clone CCR4 by its 
chromosomal location. Strain 317-5b fccr4 Ieu2) was crossed to
3 0
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CDC24 : ADEI4 1 1 2 22 - -
CDC24 : CCR44 18 0 21 - -
ADE1 : CCR4* 31 1 29 - -
TRP 1 : CCR4a - - - 4 4 1 2
*  Mapping da ta  from C. Denis (personal communication).
Figure 7a : Ini tial  mapping of CCR4.
The re l a t iv e  posi t ion of CCR4 w i th  re sp ec t  to  o th e r  genes  used 
fo r  mapping purposes on chromosome I i s  shown above. The 
d is tance  be tw een  a l l e le s  i s  not  to  scale. Genetic  d i s tan c es  
ca lcu la ted  be tw een  the  indicated genes are  : CDC24 • APE 1 = 46.6 
CM, CDC24 : CCR4 = 26.9 cM, CCR4 : APE 1 = 28.7  CM, and TRP 1 : 
CCR4 = 13.6 cM. Genetic d is tan ces  w ere  ca lcu la ted  by the  
equation:
T + 6NPDCM = 1 ^ 0
2 IPD + NPD + T
Centromere  linkage of CCR4 using the cen t rom ere  linked TRP 1 
locus (chromosome IV) w a s  e s t im a te d  as one ha lf  the second 
divis ion segrega t ion  (SDS) frequency:
cM = 0.5 I SDS IIf d s I
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Figure 7b : Diagram of the  l e f t  arm of Chromosome I.
CCR4 w a s  mapped to  the  l e f t  arm of chromosome I re la t iv e  to 
SP07 and CEN1 (see  text) .  The d irec t ion  of t r an sc r ip t io n  of CCR4 
i s  indicated  by the a r ro w  as being away from CENi (D. Kaback, 
personal  communication). Distances a re  given in centiMorgans 
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Figure 8 : Complementation of c c r 4  bu plasmid construct ions .
S t r a in  3 4 8 -2 6 c  ( c c r4 ) was  t r an s fo rm e d  w i th  p lasmid  
c o n s t ru c t io n s  conta ining sequences f rom chromosome I as 
ind ica ted  above. Complementation of the  c c r4  a l l e le  was  
de te rm ined  by the ab i l i ty  of the  t rans fo rm ed  s t r a in  to grow 
on n onfe rm en ta t ive  medium a t  37°C. Construction of the 
p lasm ids  i s  descr ibed  in the text.  R e s t r ic t io n  s i t e  designat ions  
on chromosome I are: B = BamHI and H = Hindlll.
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292-6a (trpl SPQ7:LEU2^ and the segregation pattern of ccr4 (low 
ADH II activity, see Table 2 and temperature sensitivity following 
growth on nonfermentative medium, Denis and Malvar, 1990), LELJ?. 
and trpl w as followed in 30 tetrads. The linkage of CCR4 to CEN1 
was determined by following the segregation pattern between CCR4 
and TRP1 the latter of which is tightly linked to the centromere of 
chromosome IV. The segregation pattern between CCR4 and CEN1 and 
between SPQ7 and CEN1 gave a second degree segregation (SDS) 
frequency of 0.2 (25 FDS : 5 SDS) and 0.03 ( 29 FDS : 1 SDS) 
respectively. This places SPQ7 at 1.5 cM from CEN1 and CCR4 at 10 
cM from CEN I. The segregation pattern between CCR4 and SPQ7 
provided a  ratio of 25 PD : 5 T for an estimated map distance of 8.3 
cM. The resulting data placed CCR4 on the left arm of chromosome I 
approximately 8.3 cM distal to SPQ7 and 10 cM from CEN1 (see 
Figure 7b).
Plasmid constructions pL-6.5 and YRp7-3.5 that contain 
sequences in the vicinity of CCR4 estimated from the segregation 
ratios provided above were tested for their ability to complement a  
ccr4 allele in strain 348-26c. Like YCp50-2c and pM-11.7, both
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Table 2 : E ffe c ts  of c c r4 /c re  m utations on ADH It 
a c tiv ity .
ADH alle le
Other
re lev an t
genotype




ADH21 cre l 175 2200
ADH21 c re l  c c r 4 23 500
ADH21 ere  2 77 2900
ADH21 cre2  c c r 4 6 1 10
ADH21 ADR 1 - 5 ° 280 6600
ADH21'2 ccr4 5 400
ADH21 ccr4  ADR 1 -5C 345 335
* Yeast were  grown on YEP medium supplemented  to  8% glucose 
as  descr ibed  in Materials  and Methods.
b Yeast were  grown on YEP medium supplemented  to  Z% ethanol 
as  descr ibed  in Mater ia ls  and Methods.
1 ADH II values from Denis, C.L. Genetics 108:833-844.  (1984).
2 Depending on the  genet ic  background, s t r a in s  carry ing  the 
c c r 4 - 10 a l le le  can vary b e tw een  100 to  1000 mU/mg of ADH II 
a c t iv i ty  under e thanol g rowth  conditions.
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pL-6.5 and YRp7-3.5 failed to complement the ccr4 allele (see Figure 
8).
In order to provide another selectable marker for mapping, the 
TRP1 gene was integrated into the left arm of chromosome I by 
transformation of strain 348-26c (ccr4) with BamHI restricted 
YRp7-3.5 plasmid (see Figure 3a and 3b). Analysis of the stable 
TRP1 transformant 348-26cl showed elevated ADH II activity under 
derepressed conditions and complementation of the temperature 
sensitive phenotype following growth on nonfermentative medium 
displayed by mutant CCR4 alleles (Table 3). Southern analysis of 
348-26cl confirmed two copies of YRp7-3.5+ integrated at the 
BamHI site on chromosome 1 (data not shown). Furthermore, analysis 
of 27 tetrads resulting from a cross between 348-26cl (MATo 
CCR4:TRP1) and 348-13a (MATa ccr4 trpp showed the segregation 
pattern of CCR4:TRP1. was 2 :2  with respect to trp l. and the TRP1 
phenotype segregated away from the temperature sensitive 
phenotype on nonfermentative medium. One of the tetrads from the 
above cross (segregants 350-19a, -19b,-19c, and -19d; Table 3) 
was selected and assayed for ADH II activity under ethanol growth
3 6





ADH II ac t iv i ty  
(mU/mg) 
Ethanol
3 4 8 - 2 6 c l + 3317
3 5 0 - 1 9 a 1 - 80
3 5 0 - 1 9 b 1 + 2373
3 5 0 - 1 9 c 1 - 8
3 5 0 - 1 9 d 1 + 2576
348-26C  a - 237
3 4 8 - 13a 4 - 130
3 4 8 - 2 6 c - C I 2 + 1650
a Segregen ts  of 3 1 7 -5 b  X 292 -6a .
'S e g r e g e n t s  of 3 4 8 - 2 6 c  X 3 4 8 - 13a.
2 S tra in  348-26C t rans fo rm ed  w i th  pel.  ADH II a c t iv i ty  
assayed  by growth  in medium lacking t ryptophan and 
supplemented  to  Z% ethanol.
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conditions. Elevated ADH If activity was found to cosegregate with 
CCR4;TRP1. Additionally, the presence of YRp7-3.5+ as  assayed by 
Southern analysis performed on the 350-19 segregants, 
cosegregated with the CCR4:TRP1 phenotype and elevated ADH II 
activity noted above (data not shown). These results indicate that 
the YRp7-3.5 plasmid, upon integration at the BamHI site, reformed a  
wild type CCR4 gene and eliminated the need for further mapping 
experiments 
Cloning of CCR4
While Southern analysis confirmed the integration of 
YRp7-3.5+ in strain 348-26cl, it most likely did not contain a  
complete functional copy of CCR4 since transformants harboring 
either the YRp7-3.5+ or YRp7-3.5- intact plasmid failed to show 
complementation of the mutated CCR4 allele.
In order to obtain a functional copy of CCR4. the internal 
1.5-kb BamHI to Hindlll fragment isolated from YRp7-3.5+ (see 
Figure 3b) was used to probe a  yeast genomic pool (Nasmyth and 
Reed, 1982). Two thousand colonies were screened and a single clone 
(designated pC1) was identified as displaying homology to the probe.
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Restriction analysis of pC1 showed that it represented an 
approximately 7.0-kb insert from chromosome I including sequences 
found in YRp7-3.5+ (see Figure 9). Transformation of 348-26c with 
pC1 resulted in complementation of the mutant CCR4 allele as 
assayed by AOH II activity and growth on nonfermentative plates at 
37 0 C (see strain 348-26c-C1 in Table 3 and Figure 8). Furthermore, 
the analysis of transformants selected for the loss of the pC1 
plasmid following growth on nonselective medium showed that the 
loss of pCI correlated with lowered ADH II activity and restoration 
of the temperature sensitive phenotype on nonfermentative media. 
These findings demonstrate that the pC1 construction contains a 
functional copy of the CCR4 gene.
S equsncin a j f  C CR4
The constuctions p89, YRp7-3.5+, YRp7-3.5-, pUC18-Bm-Hd, 
and pC1 (Figures 3b and 9) were used to sequence both strands of 
CCR4. Initial sequence data were generated from pUC18-BM-Hd using 
the -20 M13 and the -24 M13 (reverse) sequencing primers. 
Subsequent sequences were obtained using synthetic oligonucleotide 
primers generated from previously determined sequences. The











Figure 9 : R es t r ic t io n  map of pCI.
The cons t ruc t ion  pCI con ta ins  a funct ional  copy of CCR4 
i s o la t e d  from a YEp13 yeas t  genomic l ibrary .  Cut s i t e s  are 
show n only fo r  th o se  sequences  derived f rom  chromosome I. The 
YEp 13 sequences a re  rep re sen ted  by darkened s e c t io n s  ( ■ ■ ) ,  
w h i le  those rep re sen t ing  sequences  derived  from chromosome I 
a re  open (HU).
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sequencing strategy and the position and orientation of the primers 
are presented in Figure 10. The sequence of CCR4 predicts an open 
reading frame of 2511-bp with an estimated protein m ass of 
94.6-kDaf. The direction of transcription is away from the 
centromere (D. Kaback, personal communication). The sequence data 
agrees with both the size of the CCR4 transcript as predicted by 
Northern analysis (see below) and with the CCR4 protein identified 
by immunoprecipitation from 35S-labeled yeast cell extracts (ca. 
92-kDal; R. Vallari, personal communication). Figure 11a and 11b 
shows the complete sequence of CCR4 along with the corresponding 
amino acid sequence. A linear plot of the hydrophobic and hydrophilic 
regions the CCR4 protein is shown in Figure 12.
Protein Sequence Similarities
Analysis of the predicted amino acid sequence of CCR4 reveals 
five leucine rich tandem repeats located in the middle of the protein 
(residues 350 - 467, see Figure 11). This motif is charaterized by a 
repeating unit with a  general consensus sequence of 
P-X-X-o-X-X-L-X-X-L-X-X-L-X-L-X-X-N-X-o-X-X-o (where X -  any 
residue and o -  aliphatic amino acids, L, I, or V). A search of the
41
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Figure 10: Sequencing s t r a t e g y  fo r  CCR4.
The pos i t ion  of sy n th e t ic  p r im ers  used in sequencing CCR4 
are  shown above (■ ) .T h e  thin line (— ) is  r e p re se n ta t iv e  of 
chromosome I and the heavy line in d ica te s  the  pos i t ion  of CCR4 
(— ). The a r r o w s  indicate  the  o r ien ta t ion  of the  primers .  Initial 
sequence  da ta  w a s  generated  from pUC 18-Bm:Hd using the - 2 0  
and - 2 4  ( rev e rse )  M13 sequencing p r im e rs  as i s  descr ibed 
in th e  tex t .T h e  ex ten t  of the  sequence da ta  obtained for  each 
p r i m e r  is  shown.
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Figure 11 : DNA and protein sequence  of CCR4
a. Sequence of the CCR4 gene. The 2880-base pair sequence 
encompasing the 2511-base pair open reading frame is shown.
b. Amino acid sequence of the CCR4 protein. The five 
leucine-rich repeat units (residues # 350-476) are underlined. 
Alignment of the repeats are shown in Figure 13. Also indicated are 
the consecutive glutamine and asparagine residues (#15-24 and 




- 1 5 3  TTTTGTTATCGCCCGTACTTGCGAAAAACGGGCCAACAACGAAAAAATTTGAAAAAGTTT 
CCACCTTAGAGAAGGTTCTCAAGCACAAGGGCACAGCATAAGGGACACCAGCAAGGGAAC 
- 3 3  TCCGACTGACGTTATCCCTGCAAACTACCGCTA
ATGAACGACCCTTCTTTACTAGGCTAC 
CCTAATGTGGGCCCGCAGCAGCAACAGCAACAGCAGCAACAGCAGCATGCCGGGCTACTA 
8 8  GGAAAGGGTACACCAAACGCTCTACAGCAGCAGCTACACATGAACCAGCTCACCGGGATA 
CCTCCACCGGGACTCATGAACAACAGCGATGTACACACTTGCAGCAACAACAACTCGCGC 
2 0 8  CAGTTGCTCGACCAATTGGCTAATGGGAACGCGAACATGCTCAATATGAACATGGATAAC 
AACAATAACAACAATAACAACAACAACAACAACAACAACAACGGCGGTGGAAGCGGGGTG 
3 2 8  ATGATGAATGCCTCCACAGCCGCAGTAAATTCTATAGGGATGGTTCCTACCGTTGGTACG 
CCTGTGAACATCAATGTGAACGCCAGTAACCCTTTATTACACCCGCACTTGGATGACCCT 
4 4 8  TCTTTACTAAACAATCCGATCTGGAAGCTTCAATTGCATCTGGCTGCAGTGTCCGCACAA 
TCTCTGGGGCAACCCAAGATTTATGCTAGACAAAACGCTATGAAGAAGTATTTGGCTACA 
5 6 8  CAACAGGCTCAGCAAGCTCAGCAACAAGCGCAGCAACAGGCACAGCAGCAGGTCCCGGGC 
CCATTTGGCCCCGGACCTCAGGCTGCACCACCAGCTTTGCAGCCCACCGATTTCCAGCAA 
6 8 8  TCTCACATTGCAGAAGCCTCCAAATCACTGGTSGACTGCACAAAGCAAGCCTTGATGGAA 
ATGGCCGACACTCTCACCGACAGCAAGACAGCAAAGAAACAACAACCTACGGGAGATAGC 
8 0 8  ACTCCCTCAGGCACGGCAACTAACAGTGCAGTTTCTACACCATTGACTCCCAAGATAGAG 
CTGTTTGCTAATGGCAAGGACGAAGCCAACCAGGCGCTCTTACAACACAAGAAACTGTCT 
9 2 8  CAGTACAGCATCGACGAAGATGACGACATTGAAAACAGAATGGTCATGCCCAAGGACTCG 
AAATACGACGACCAATTATGGCACGCGCTAGATTTGTCCAACTTGCAAATCTTCAATATC 
1 0 4 8  AGCGCCAACATCTTCAAGTACGATTTTCTAACGAGACTATATTTGAATGGCAATAGCCTC 
ACGGAACTGCCAGCGGAGATCAAGAACCTAAGCAACCTACGCGTTTTGGACCTGTCGCAT 
1 1 6 8  AATAGGTTAACATCTCTACCAGCGGAACTAGGCTCATGTTTCCAATTGAAATACTTCTAC 
TTTTTTGATAACATGGTCACCACATTACCATGGGAGTTTGGGAACCTGTGTAACCTTCAG 
1 2 8 8  TTTCTTGGTGTAGAAGGAAACCCCTTAGAAAAACAGTTTTTAAAGATCCTTACAGAAAAA 
TCTGTCACGGGATTGATTTTCTACCTAAGGGACAACAGACCAGAGATTCCCTTACCGCAT 
1 4 0 8  GAACGTAGGTTCATCGAAATCAATACCGATGGGGAACCACAGAGGGAGTACGATTCTTTG 
CAGCAATCCACTGAGCATCTGGCCACCGATTTAGCCAAGAGGACGTTCACCGTCTTATGC 
1 5 2 8  TACAACACCTTATGTCAACACTATGCCACCCCAAAAATGTACCGTTACACACCGTCGTGG 
GCGTTAAGTTGGGATTACAGGCGCAATAAATTAAAGGAGCAGATTCTCTCGTACGACAGT 
1 6 4 8  GATCTGTTGTGTTTACAAGAAGTGGAGTCTAAGACTTTTGAAGAGTATTGGGTGCCCCTA 
TTGGACAAGCACGGTTATACAGGCATCTTCCATGCAAAGGCAAGAGCCAAGACCATGCAT 
1 7 6 8  TCCAAGGACTCCAAGAAAGTGGACGGGTGTTGCATTTTTTTCAAAAGGGACCAATTCAAG 
TTGATCACCAAAGACGCCATGGATTTCAGCGGTGCTTGGATGAAACACAAGAAGTTCCAA 
1 8 8 8  AGAACTGAAGATTATTTAAACCGTGCAATGAACAAAGACAACGTTGCACTGTTCTTAAAG 
CTACAACACATTCCTAGTGGCGACACCATATGGGCGGTCACCACGCATTTGCACTGGGAT 
2 0 0 8  CCAAAATTTAATGATGTGAAGACATTCCAAGTAGGTGTCCTGTTAGATCATCTGGAAACG 
CTGCTAAAGGAGGAGACATCGCACAATTTTAGACAGGACATTAAGAAATTTCCTGTGCTC 
2 1 2 8  ATTTGTGGTGACTTCAATTCATACATCAACTCCGCCGTATACGAATTGATAAATACAGGC 
CGTGTCCAAATACATCAAGAGGGAAATGGTAGAGATTTCGGTTACATGTCGGAGAAAAAT 
2 2 4 8  TTCTCACATAACTTGGCTCTCAAATCAAGTTATAATTGTATCGGAGAACTACCATTCACC 
AATTTCACACCGTCATTCACAGATGTTATCGACTATATATGGTTTTCTACACATGCTCTA 
2 3 6 8  AGGGTGCGTGGGCTATTGGGTGAAGTGGACCCTGAATACGTGAGTAAGTTTATCGGGTTC 
CCCAACGACAAATTCCCCAGTGACCATATACCATTGTTAGCAAGATTTGAATTTATGAAG 
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MNDPSLLGYPNVGPQQQQQQQQQQHAGLLGKGTPNALQQQLHMNQLTGIP 50 
PPGLMNN S DVHT SSNNN SRQLLDQLANGNANMLNMNMDNNNNNNNNNNNN 100 
NNNGGGSGVMMNASTAAVNSIGMVPTVGTPVNINVNASNPLLHPHLDDPS 150 
LLNNPIWKLQLHLAAV SAQSLGQPNIYARQNAMKKYLATQQAQQAQQQAQ 200 
QQAQQQVPGPFGPGPQAAPPALQPTDFQQSHIAEASKSLVDCTKQALMEM 2 5 0  
ADTLTDSKTAKKQQPTGDSTPSGTATNSAVSTPLTPKIELFANGKDEANQ 300  
ALLQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIFNIj> 350  
ANIFKYDFLTRLYLNGNSLTELPAEIKNLSNLRVLDLSHNRLTSLPAELG 4 0 0  
SCFQLKYFYFFDNMVTTLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKS 450  
V TGLIFY LRD N RPEIPLPHERRFIEINTDGEPQREYDSLQQSTEHLATDL 500  
AKRTFTVLSYNTLCQHYATPKMYRYTPSWALSWDYRRNKLKEQILSYDSD 550  
LLCLQEVESKTFEEYWVPLLDKHGYTGIFHAKARAKTMHSKDSKKVDGCC 600  
IFFKRDQFKLITKDAMDFSGAWMKHKKFQRTEDYLNRAMNKDNVALFLKL 6 5 0  
QHIPSGDTIWAVTTHLHWDPKFNDVKTFQVGVLLDHLETLLKEETSHNFR 700  
QDIKKFPVLICGDFNSYINSAVYELINTGRVQIHQEGNGRDFGYMSEKNF 7 5 0  
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Figure 12 : Hydrophobic and hydrophilic regions of the CCR4 protein.
A linear plot of the hydrophilic and hydrophobic regions of the 
CCR4 protein generated by the algorithm of Kyte and Doolittle 
(1982) in the DNA Stryder sequence analysis program. Residues 15 to 
24 and 89 to 103 represent consecutive glutamine and asparagine 
residues, respectively. Residues 190 to 206 represent the repeat Q Q 
A Q Q A Q Q Q A Q Q Q A Q Q Q .  The leucine rich tandem repeats are 
represented by residues 350 to 467. Negative values indicate an 
increasing hydrophilic nature.
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National Biomedical Research Foundation database showed that CCR4 
shares similarities in this region with a  family of proteins 
displaying a similar leucine rich repeat motif. These proteins are 
found in a  wide-range of species and include the yeast adenylate 
cyclase (Kataoka et al., 1985), both the human placental (Lee et at., 
1988) and porcine liver (Hofsteenge et al., 1988) RNase inhibitor, 
the human leucine rich oc 2 glycoprotein (Takahashi et al., 1985), the 
human 83-kDal subunit of carboxypeptidase N (Tan e t al., 1990), the 
human platelet glycoprotein lb o subunit (Lopez et al., 1987), 
proteoglycan I and II from both human (Fisher etal., 1989) and 
bovine (Day et al., 1987, Neame et al., 1989), the lutropin- 
choriogonadotropin receptor from rat (McFarland et al., 1989), and 
the Toll (Hashimoto et al., 1988) and chaoptin (Reinke et al., 1988, 
Krantz and Zipursky, 1990) proteins from Drosophila. These proteins 
are found to be located either extracelluar, intracellular, or 
membrane bound (Kataoka et al.,1985, Lee e t al.,1988, Hofsteenge e t 
al.,1988, Takahashi et al.,1985, Tan etal.,1990, Lopez e t al.,1987, 
Fisher e t al.,1989, Neame et al.,1989, McFarland et al.,1989,
Hashimoto et al.,1988, and Reinke et al.,1988).
The proteins share a  common functional relationship in 
mediating interactions at either a protein : protein, a  protein : cell, 
or a ce ll: cell level. Examples of which are the human placental 
ribonuclease inhibitor which binds RNase at a 1 :1 stoichiometry 
(Lee et al., 1988) and the human platelet membrane glycoprotein lb 
which is involved in the interaction between the platelet and von 
Willebrand factor (Titani et al., 1987). Krantz and Zipursky (1990) 
have shown that chaoptin, a Drosophila photoreceptor cell specific 
protein is required for proper development of and adhesion between 
photoreceptor cells. The similarity shared between CCR4 and a  
family of proteins thought to participate in the mediation of 
interactions between various moieties suggests that CCR4 may act 
in a  similar capacity. CRE1, CRE2, or components of the 
transcriptional machinery are possible candidates that bind CCR4 
(see below). Figure 13 compares the leucine rich tandem repeats 
found in CCR4 to those previously described.
The N-terminal quarter of the CCR4 protein contains several 
unusual blocks of residues. This region contains 10 consecutive 
glutamine residues (#15 - 24), 15 consecutive asparagine residues
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Figure 13 : Homology shared between CCR4 and a  family of 
proteins displaying a  leucine rich tandem repeat array.
a. Alignment of the 5 copies of the leucine rich repeats 
found in the CCR4 protein (residues 350 - 467). Conserved 
residues are indicated by being enclosed in boxes. The general 
consensus sequence is shown below (x -  any amino acid, * = 
aliphatic amino acids leucine, isoleucine, or valine).
b. The general consensus sequence for CCR4 is compared to 
those of other proteins displaying the leucine rich repeating
motif. Aliphatic amino acids leucine, isoleucine, or valine are 
indicated by (*); x = any residue. The consensus sequences are 
from: adenylate cyclase (Kataoka et al., 1985), Toll (Hashimoto et 
al., 1988), chaoptin (Reinke et al., 1988), RNase inhibitor (human : 
Lee et al., 1988; porcine : Hofsteenge etal., 1988), platelet 
glycoprotein lb o (GPIb o : Lopez et al., 1987), and the leucine 
rich o 2 glycoprotein (GP : Takahashi et al., 1985).
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Alignment of  the  leucine r ich  re p e a t s  found in CCR4
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rep ea ts Consensus of rep ea ted  sequence
CCR4 (Y east) 5
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(#89 -103), and the repeat sequence: Q Q A Q Q A Q Q Q A Q Q Q A Q Q  
Q (residues 190 - 206). Interestingly, glutamine and asparagine 
residues account for 35% of the first quarter of the protein. This 
region shows no significant similarity to current sequences 
contained in the National Biomedical Research Foundation database. 
However, several proteins from other sources have recently been 
identified that display high glutamine content. Among these are the 
amino-terminal region of the TATA binding factor TFIID from both 
human (Kao et al., 1990) and Drosophila (Hoey et al., 1990), the 
mammalian transcriptional activator SP1 (Kadonagaetal., 1987), 
and the yeast transcriptional regulatory protein SPT13 (GAL11) 
(Fasslerand Winston, 1989).
Transcript Identification and Carbon Source Regulation
Northern analysis on total RNA harvested from strain 
FW712-1 d (CCR4 CRE1 CRE21 was performed using an internal 738 bp 
Haelll fragment of CCR4 isolated from pUC18-Bm:Hd. A single 
transcript showing homology to the probe identified CCR4 a s  shown 
in Figure 14, lane a. The size of the CCR4 transcript was estimated 
from its mobility relative to the 25S and 18S ribosomal RNA bands
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visualized by ethidium bromide in a duplicate gel (see Materials and 
Methods). The estimated transcript size is 2.8-kb and is consistent 
with an open reading frame of 2511-bp as predicted by the sequence 
data.
The regulation of CCR4 mRNA levels by carbon source 
availability was tested. Total RNA was harvested from strain 
FW712-1d grown in both glucose- and ethanol-containing medium 
and was subjected to Northern analysis a s  described above. Lanes b 
and c in Figure 14 represent equal amounts of total RNA loaded as 
described in Materials and Methods. Densitometric analysis of the 
signal from the CCR4 transcripts demonstrated that they are present 
in equal amounts under both fermentative and nonfermentative 
growth conditions. This data provided evidence that the abundance of 
the CCR4 transcript is not dependent on carbon source.
Effects of the CRE Alleles on CCR4 Transcription
In order to clarify how the CRE and CCR4 genes interact, the 
effect of a  crel or ££s2 on CCR4 mRNA levels was tested. Northern 
analysis on total RNA from isogenic strains 500-16 (CRE1 CRE2 
CCR4). 500-16-1 fcrel CRE2 CCR4). and 500-16-14 fCRE1 cre2
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Figure 14 : T he effect of carbon source on CCR4 mRNA levels.
CCR4 mRNA levels were measured in strain FW712-1d fCCR4 
CRE1 CRE2) following growth on either glucose or ethanol 
containing media. CCR4 mRNA was identified as a  2.8-kb transcript 
under glucose growth conditions (lane a). Northern analysis of CCR4 
mRNA was performed on approximately three-micrograms of total 
RNA from cells grown on glucose containing medium (lane b) and 
ethanol containing medium (lane c).
A dulpicate gel stained with ethidium bromide for lanes b 
and c is displayed in the bottom panel and shows the level of the 
18s rRNA. The levels of 18s rRNA and CCR4 mRNA were found to be 





C.CB4) was performed. The level of CCR4 transcript was readily 
detectable in all three strains (see Figure 15). Densitometric 
analysis showed an approximately 1.5 fold increase in CCR4 
transcript levels in the presence of the cce alleles. Defects in the 
CRE alleles have been shown to be pleiotropic in their effect on 
transcription and other cellular processes (Denis, 1984, Denis and 
Malvar, 1990). Therefore, the modest increase seen in CCR4 
transcript level may reflect a  more general increase in 
transcriptional activity within the cell.
Functional Analysis of CCR4
To identify regions in the CCR4 protein of functional 
importance, a series of disruptions and deletions were constructed 
within the coding region of CCR4 (Figure 16). Plasmid pC1 :HIS3 
contains the yeast HIS3 gene inserted at bp 2004 that would result 
in a  truncated CCR4 protein of 668 amino acids (CCR4:1-668; see 
Figure 4). The plasmid pUC18-Bm:Hd:HIS3 contains the yeast HIS3 
gene placed at bp 1175 that would result in a  truncated CCR4 protein 
of 392 amio acids (CCR4:1-392; see  Figure 5). The plasmid 
YRp7-3.5:delta Mlul-Hincll contains an inframe deletion of the region
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Figure 15 : The effect of the CRE alleles on CCR4 mRNA levels.
Northern analysis on CCR4 mRNA was performed on equal 
amounts of total RNA harvested from strains 500-16 (CRE1 CRE2 
CCB4), 500-16-1 (crel CRE2 CCR41. and 500-16-14 fCRE1 cre2 
CCR4^ following growth on glucose containing medium. 
Densitometric analysis showed the level of CCR4 mRNA did not 
vary significantly regardless of the allelic state of the CRE genes.
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Figure 16: Disruptions and dele t ions c rea ted  in CCR4.
The thin l ine ( — ) r e p re se n t s  sequences f rom  the l e f t  arm of 
chromosome I. The pos i t ion  and o r ien ta t ion  (arrow) of CCR4 
i s  a lso shown. Sequences contained on p lasm ids  used to  c re a te  
de le t ions  and d is rup t ions  in CCR4 a re  shown below. T he i r  
co n s t ru c t io n  is  descr ibed  in the t e x t  and Figures 5 (pCI:HIS3),
6 (pUCia-Bm:Hd:HIS3), and 7 (YRp7-3.5:deltaMlul-Hincll).
5 8
from bp 1146 -1543 in the CCR4 gene. This would result in a CCR4 
protein of 704 amino acids in length (CCR4:1-382/514-837; see 
Figure 6).
The effects of the constructions described above were tested 
in strains 82-2b (crel CCR4). and 612-1 d (CRE1 CCR41. Strain 82-2b 
allows for the assessm ent of the ability of the disruptions in CCR4 
to suppress crel -induced effects. Strain 612-1 d was used to 
determine if the disruptions created in CCR4 would result in 
increased ADH II activity under glucose repressed growth conditions. 
Replacement of the endogenous CCR4 gene in strain 82-2b with 
CCR4:1-668 (using plasmid pCI:HIS3) resulted in a  temperature 
sensitive phenotype following growth on nonfermentative medium 
and sensitivity to antimycin A (Strain 82-2b-A; see Table 4 a).
Strain 82-2b-A did display, however, a  slight resistance to 
antimycin A after prolonged growth. This is consistent with the 
slight decrease in ADH II activity measured under glucose growth 
conditions that the CCR4:1-668 allele caused (see Table 4 b).
Strain 82-2b-1 contains the CCR4:1 -392 allele placed at the 
chromosomal locus of CCR4 using plasmid pUC18-Bm:Hd:HIS3. The
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Table 4
a. Deletions and disruption constructed in CCR4 were used 
to transform yeast strains as described in the text. Plasmid 
pCI:HIS3 was used to construct the carboxy-terminal disruption 
of CCR4 (CCR4:1-668: strain 82-2b-A). The plasmid 
pUC18-Bm:Hind:HIS3 was used to construct a  disruption of the 
leucine rich repeats in CCR4 (CCR4:1-392; strain 82-2b-1). The 
inframe deletion generated by the construction of 
YRp7-3.5:deltaMlul- Hindi (CCR4:1-382/514-837) was 
integrated at the TRP1 locus of 82-2b-1 to give strain 
82-2b-1-1a. Strain 82-2b-1-a has a wild type copy of CCR4 
contained on the plasmid YRp7-3.5+ integrated at the TRP1 locus 
of 82-2b.
Strain 612-1 d was disrupted at the CCR4 locus using the 
pCI:HIS3 construction (CCR4:1-668) to give strain 612-1d-2.
Strain 85-1 c is a  segregant of the cross 82-2b-1 X 612-1 d and 
carries the CCR4 disruption created using the pUC18-Bm:Hd:HIS3 
(CCR4:1-392) in a  wild type CRE background.
b. ADH II activity values for strains harboring the 
disruptions of CCR4 described above. Activity values were 
measured following growth on glucose or ethanol containing 
media as indicated (see Materials and Methods).
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Table 4  : E ffec ts  o f disruptions and deletions in CCR4 
on s tra in s  8 2 -2 b ,  6 1 2 - Id , and 8 5 - 1c.
A.
Strain HI S3 TRP1 AT
Growth 
YD YET 
30 37 30 37
GLY 
30 37
82-2b - - + + + + + + +
82-2b-A + - — + + + - +
8 2 -2 b -1 + - — + + + - +
8 2 -2 b -1-a + + + + + + + + +
8 2 -2b -1 -1a + + - + + + - +
612— 1 d - - - + + + - + -
612-1d-2 + - — + + *  — + -
8 5 - 1c + - - *  + + - + -
B.
ADH II a c t iv i ty
(mU/mg)
Stra in Glucose Ethanol
82-2b 105 n.d.
8 2 -2b -A 66 n.d.
8 2 - 2 b - 1 32 n.d.
8 2 - 2 b - 1 - a 2 3 5 n.d.
8 2 - 2 b - 1-1 a 22 n.d.
6 1 2 - Id n.d. 4 0 0 0
6 1 2 - Id -2 n.d. 750
8 5 - 1c n.d. 800
n .d : not  de te rmined
61
resultant CCR4:1-392 allele that lacks all but two copies of the 
leucine rich repeats and the CCR4:1-668 allele displayed similar 
phenotypes. Both disruptions in CCR4 suppressed the resistance to 
antimycin A that is conferred by a crel allele. This result further 
demonstrated the epistatic relationships previously described 
between the CCR4 and CRE alleles (Denis, 1984). Strain 82-2b-1 
fCCR4:1-3921 shows no resistance to antimycin A, however, even 
after prolonged growth. This observation is consistent with the low 
ADH II activity on glucose growth conditions caused by the 
CCR4:1-392 allele (see Table 4 b).
The plasmid YRp7-3.5+ was integrated into strain 82-2b-1 in 
order to determine if a wild type copy of CCR4 could rescue the 
phenotype caused by the CCR4:1-392 allele. Plasmid YRp7-3.5+ 
failed to complement a  ccr4 a llele in plasmid form even though 
sequence data for CCR4 indicated that it contained the complete 
coding region of CCR4 (discussed below). Strain 82-2b-1-a which 
represents a  wild type copy of CCR4 integrated at the TRP1 locus, 
restored the phenoype observed in 82-2b (see Table 4  a). 
Additionally, ADH II activity in strain 82-2b-1 -a was increased two
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fold under glucose growth conditions compared to strain 82-2b. This 
observation may reflect differences in the sequences flanking the 
CCR4 allele in terms of its overall level of expression (see below).
The construction pCI:HIS3 fCCR4:l-668) was used to create a  
disruption of CCR4 in strain 612-1 d in order to determine its effect 
in a  wild type CRE background. Table 4a shows that the replacement 
of the chromosomal CCR4 gene with the CCR4:l-668 allele (strain 
612-1d-2) resulted in a temperature sensitive phenotype following 
growth on nonfermentative medium and a  5-fold reduction in ADH II 
activity under ethanol growth conditions. Attempts to create a 
disruption in 612-1 d using the pUC18-Bm:Hd:HIS3 construction were 
unsuccessful. As an alternative, strain 82-2b-1 which harbors the 
disruption created with pUC18-Bm:Hd:HIS3 (CCR4:1-3921 was 
crossed to 612-1 d and an appropriate segregant carrying a  wild type 
CRE1 allele and the disrupted CCR4 allele was identified (strain 
85-1 c). Analysis of 85-1 c showed that it, like 612-1d-2, displayed 
a  temperature sensitive phenotype following growth on 
nonfermentative medium (see Table 4a). Furthermore, derepressed 
ADH II activity values for 85-1c and 612-1d-2 were approximately
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equal (see Table 4b). Analysis of the strains harboring the 
disruptions described above show that they are phenotypically 
similar to the mutations isolated in CCR4 as  described by Denis 
(1984) and Denis and Malvar (1990).
The inframe deletion of CCR4 (CCR4:1 -382/514-8371 was 
integrated at the TRP1 locus in strain 82-2b-1 using the plasmid 
YRp7-3.5:delta Mlul-Hincll to give strain 82-2b-1-1a. The 
CCR4:1 -382/514-837 allele that contains only one full copy of the 
leucine rich repeats but the sequences to the C-terminal side of the 
leucine rich repeats, gave a phenotype identical to those seen in the 
disruptions of CCR4 described above, ie. temperature sensitivity 
following growth on nonfermentative medium and anyimycin A 
sensitivity. ADH II activity for strains 82-2b-1-1a and 82-2b-1 
were nearly identical and represented an approximately 4-5-fold 
decrease in activity when compared to strain 82-2b.
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IV. DISCUSSION 
Genetic studies by Denis (1984) identified components of a 
second pathway involved in the transcriptional regulation of the 
yeast glucose-repressible ADH II. The crel and cre2 alleles were 
identified as mutations allowing for the expression of ADH2 under 
glucose repression. Mutations which bypass ccg-induced ADH2 
expression under fermentative growth fall into a single 
complementation group designated ccr4. Allelism has been shown 
between £RE2, SPT6. and SSN20: mutations in which cause increases 
in ADH2. SUC2. and his4-912delta transcription (Denis and Malvar, 
1990; Neigeborn et al., 1987; Clark-Adams and Winston, 1987). 
Additionally, Clark-Adams and Winston (1987) and Neigeborn e t al.
(1987) have shown that SPT6 and SSN20 are essential yeast genes. 
Strains carrying a cre2 allele were shown to display a  temperature 
sensitive phenotype which also implies that it is an essential gene 
(Denis and Malvar, 1990). CRE1 is allelic to SPT1Q. another member 
of the SPT gene family (Fassler and Winston, 1988). Like CRE2. 
mutations in CRE1 allow for increased ADH2 and his4-912delta
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transcription (Denis and Malvar, 1990). The epistatic relationship 
described between the CRE alleles and CCR4 (Denis, 1984) is evident 
by the observations that mutations in CCR4 s u p p r e s s  c r e - i n d u c e d  
effects at both the ADH2 and his4-912delta loci (Denis and 
Malvar,1990).
This study characterizes CCR4 and addresses the role it may 
play in the regulation of ADH2 transcription. CCR4 resides on the 
left arm of chromosome I (Figure 4). The genetic distance between 
CCR4 and CEN1 provided by the segregation ratios from the cross 
between 317-5b and 292-6a was calculated to be 10 cM. The 
physical distance between CCR4 and CEN1 is approximately 37-kb. 
The reported ratio of physical to genetic distance on chromosome I 
is 2.6 kb/cM (Mortimer and Schild 1985) and differs from that 
calculated by the mapping data for CCR4 (3.7 kb/cM). This 
discrepancy may be due to a  region of hypo-recombination that lies 
between CEN1 and SPQ7 (D. Kaback, personal communication). The 
plasmid pCI (Figure 9) was shown to contain a functional copy of 
CCR4 by its ability to complement the temperature sensitive 
phenotype and low nonfermentative ADH II activity in strain
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348-26C which harbors a  ccr4 -l0  allele (Table 3).
The protein coded for by the 2511-bp open reading frame of 
CCR4 has an estimated mass of 94.6-kDal. Analysis of the DNA 
sequence for CCR4 shows no TACTAAC consensus sequence for intron 
splicing. The predicted mRNA and protein sizes agree with the 
Northern analysis of CCR4 mRNA which shows a  single transcript 
with an estimated size of 2.8-kb (Figure 14, lane a) and a 92-kDal 
protein specifically precipitated by antibodies raised against a 
synthetic polypeptide to the predicted carboxy-terminal domain of 
CCR4 (R. Vallari, personal communication). Analysis of the CCR4 
protein shows that it contains 5 tandem copies of a  leucine rich 
repeat (residues 350 - 467). These repeats reside in the middle of 
the protein and are bordered by two relatively hydrophilic domains 
(Figure 12).
The sequence data indicate that the coding region for CCR4 is 
contained within the 3.5-kb Bglll fragment that is present in 
YRp7-3.5. This is further supported by the observation that 
YRp7-3.5+ integrated at the TRP1 locus of strain 82-2b can 
complement a  ccr4 allele (see strain 82-2b-1 -a; Tables 4a and 4b).
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These results are in contrast to the observation that neither of the 
intact YRp7-3.5 plasmids are capable of complementing a  CCR4 
mutation. The explanation for this discrepancy may be the fact that 
increased levels of CCR4 on plasmid borne copies is detrimental to 
cell growth. The YRp7 based vectors exist at a greater copy number 
(50-100) within the cell than YEp13 based vectors (20-30) from 
which pC1 is derived. Additionally, slow growth has been  noticed in 
strains harboring plasmid borne wild type copies of CCR4. including 
those strains harboring pC1, when compared to strains containing 
only the endogenous CCR4 allele.
The level of CCR4 transcription is not significantly altered by 
either carbon source (see Figure 13, lanes b and c) or a  crel or cre2 
allele (see Figure 15). Immunoprecipitation of the CCR4 protein 
showed that levels remain unchanged in a s  strains when compared 
to a  wild type CRE background (R. Vallari, personal communication). 
Additionally, CCR4 protein levels were found to be similar following 
growth on fermentative and nonfermentative medium (1.7 fold 
increase in nonfermentative medium over that observed in 
fermentative growth conditions, R. Vallari, personal
communication).
Since the levels of CCR4 mRNA and protein remain constant 
regardless of the available carbon source or state of the CRE alleles, 
the interaction between CCR4 and the CRE alleles (Denis, 1984; 
Denis and Malvar, 1990; this study) appears to occur directly or 
indirectly at a protein level. Similarities between CCR4 and proteins 
displaying the leucine rich tandem repeats support this idea. Several 
findings demonstrate the role of leucine rich repeats in mediating 
protein interactions. Deletions of single or multiple copies of the 
repeats found in the human placental ribonuclease inhibitor disrupts 
the inhibitor's ability to bind to and (or) inactivate RNase (Lee and 
Vallee, 1990). Tan et al. (1990) suggest that the association of the 
human carboxypeptidase N 83-kDal subunit with the 50-kDal 
catalytic subunit occurs through the leucine rich repeats. The 
repeats were not responsible for the interaction between the human 
platelet glycoprotein lb (GP lb) and von Willebrand factor (Vicente et 
al., 1990). However, they report that the ability of GP lb to exist in 
circulation with von Willebrand factor prior to interaction may be 
due to changes in the GP lb receptor. These changes may be in the
form of an unidentified antagonistic substance(s). This is based on 
their observation that association between GP lb and von Willebrand 
factor is seen after the platelets are exposed to high shear stress.
The binding of an antagonist to the repeats which lie adjacent to the 
von Willebrand factor association site on GP lb may prevent undue 
interaction. Leucine rich repeats found in the yeast adenylate 
cyclase are reported to play a role in membrane adhesion (Kataoka et 
al., 1985). Their studues show that the protein sequence contains no 
membrane spanning domain and that deletion of the repeats results 
in cyclase activity being found in the soluble instead of the 
membrane pellet of detergent free yeast cell extracts. It is not clear 
if adenylate cyclase interacts directly with the membrane or is 
associated with a membrane embedded protein. The identification of 
the leucine rich repeat motif in a  wide variety of species suggests 
an important functional role for this domain in proteins involved in 
association.
A series of disruption and deletions were constructed within 
the coding sequences of CCR4 in order to identify regions of 
importance (Table 4 a  and 4b; Figure 16). Strains harboring any of
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the disrupted alleles of CCR4 (82-2D-A fCCR4:i-668l 82-2b-1 
(CCR4:1-392). 612-1d-2 (CCR4:1-668). and 85-1c fCCR4:1-392): 
Table 4a) are phenotypically similar to previously described 
mutations in CCR4: in showing temperature sensitivity following 
growth on nonfermentative media (Denis, 1984; Denis and Malvar, 
1990). This phenotype was also observed in strain 82-2b-1a which 
contains the inframe deletion of the leucine rich repeats 
(CCR4:1 -382/514-837: Table 4a; Figure 8). Additionally, the effects 
of CCR4 disruptions and deletions on ADH II activity are also seen 
(Table 4b). Strain 82-2b displays the typical elevated repressed 
activity seen in a crel background. Strain carrying mutations which 
disrupt CCR4 (82-2b-A, 82-2b-1, and 82-2b-1 -1a) act to lower the 
repressed ADH II activities by varying amounts. The glucose activity 
values for strains 82-2b-1 and 82-2b-1-1a are approximately 4-5 
fold lower than that seen  in strain 82-2b and is evident by their 
sensitivity to antimycin A (see Table 4a and 4b). Strain 82-2b-A 
has an ADH II activity that is 2-fold higher on glucose containing 
media when compared to strains 82.-2b-1 and 82-2b-1-1a (see  Table 
4b). As a  result, strain 82-2b-A displays a slight resistance to
antimycin A after prolonged growth. This suggests that the protein 
resulting from the CCR4:1-668 allele retains partial function. The 
wild type 612-1 d displays characteristic derepressed levels of ADH 
II activation which are lowered in strains carrying the disruptions 
in CCR4 (612-1d-2 and 85-1 c). These results imply that CCR4 is not 
an essential yeast gene. However, as the persistent temperature 
sensitive phenotype and lowered ADH II activity (Table 2) indicate, 
it plays a  required role in derepression at the ADH2 locus. 
Additionally, the temperature sensitive phenotype observed under 
nonfermentative growth conditions of strain 82-2b-1-1a implies 
that the leucine rich repeats are required for proper function (see 
Table 4a and 4b; Figure 16). However, providing a functional protein 
is made, a  model where the leucine rich repeats are solely 
responsible for interaction with the CRE proteins is unlikely since 
strain 82-2b-1-1a is antimycin A sensitive. It should be noted that 
the inframe deletion of the leucine rich repeats described in Figure 
6 was confirmed by sequencing (data not shown).
ADH II activity under glucose growth conditions increases 
approximately 2-fold when the YRp7-3.5+ vector is inserted at the
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TRP1 locus of strain 82-2b-1 (see strain 82-2b-1-a; Table 4b). This 
may reflect an overstimulation of transcription from the integrated 
CCR4 allele due to adjacent pBR322 sequences contained on the YRp7 
vector (Beier and Young, 1982). This is in contrast to the observation 
that there is no increase in ADH II activity under glucose growth 
conditions when CCR4 dosage is increased by transforming with the 
plasmid pCI. Strain 612-1 d transformed with plasmid pCI remains 
sensitive to antimycin A and shows a  repressed ADH II activity equal 
to that seen for 612-1d without pCI (data not shown). Strain 
348-26c-CI which harbors the pCI plasmid complements the 
temperature sensitive phenotype on YET medium and increases ADH 
II activity 7-fold on ethanol containing media when compared to 
348-26c (See Table 3) yet remains sensitive to antimycin A (data 
not shown). These results may be reconciled by considering the 
relative level of overexpression of CCR4 in each case. Large 
increases in CCR4 dosage, as would be expected in transformations 
with pCI, appear to be detrimental to cell growth as  noted above.
CCR4 transcription induced by adjacent pBR322 sequences when 
YRp7-3.5 is integrated at the TRP1 locus may not achieve levels
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that would b© detrimental to cell growth. An alternative explanation 
may lie in the ability to detect a  two-fold increase in ADH II 
activity. A two-fold increase in the ADH II activity values under 
glucose growth conditions in a  crel background (ie. from 105 to 235 
mil; see strains 82-2b-1 and 82-2b-1-a; Table 4b) is more readily 
detectable than a  similar increase from wild type levels of ADH II 
activity {ie. 8 mU on glucose growth medium; see Table 2).
The amino-terminal domain of CCR4 contains several unusual 
blocks of amino acids. This region shows similarities to the amino- 
terminal domain of the TATA box binding factor TFIID from both 
human and Drosophila {Peterson et al., 1990; Hoey et al., 1990; Kao 
et al., 1990). As described above, CCR4 contains a  block of 10 
consecutive glutamine and 15 consecutive asparagine residues along 
with the repeat Q Q A Q Q A Q Q Q A Q Q Q A Q Q Q ; a l l  residing within 
the first 206 residues {see Figure 11). Human TFIID contains 38 
consecutive glutamine residues while TFIID from Drosophila 
displays two blocks of 6 and 8 glutamines each within their 
respective amino termini (Peterson et al., 1990). Additionally, the 
amino terminus of CCR4, like both human and Drosophila TFIID, is
74
rich in proline, methionine, and serine or threonine. In comparison,
the yeast TFIID (Eisenmann eta!., 1989; Horikoshi etat., 1989;
Schmidt et al., 1989) shares similarity with the DNA binding
carboxy-terminal domain of human and Drosophila TFIID but lacks
the amino-terminal domain altogether (Figure 17). The mammalian
transcriptional activator SP1 also contains a glutamine rich domain
that appears to play a role in its ability to activate transcription
(Mitchell and Tjian, 1989). However, SP1 does not contain the
extensive blocks of glutamine residues found in CCR4 and TFIID.
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F ig u re  17 : Com parison  of t h e  TFIID s e q u e n c e s  b e tw e e n  
s p e c i e s .  The f i l l e d  in s e g m e n t s  r e p r e s e n t  t h e  conserved  
DNA binding domains .
What role may CCR4 play in transcriptional regulation? Two
recent review articles (Ptashne and Gann, 1990; Lewin, 1990)
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summarize the action of transcriptional activators and their 
relationship to TFIID. Ptashne and Gann (1990) propose two classes 
of transcriptional activators. First, 'universal' activators consist of 
proteins containing two distinct domains; one enables binding to 
DNA and the other, characterized by an 'acidic blob', serves to 
activate transcription. The second class represents activators that 
contain only one of the required domains and therefore require a 
second protein to provide the missing domain. Studies indicate that 
TFIID is the target seen directly or indirectly by both classes of 
transcriptional activators (Sringer et al., 1990; Kelleher et al.,
1990; Berger et al., 1990; Pugh and Tjian, 1990; Peterson et al., 
1990; review: Ptashne and Gann, 1990; Lewin, 1990). The ability of 
activators to contact TFIID is apparently dependent on the amino 
terminus of TFIID and the presence of additional factor(s) or 
'co-activators' (Kelleher et al., 1990; Berger et al., 1990; Stringer 
et al., 1990; Pugh and Tjian, 1990; Peterson et al., 1990). Although 
co-activators have yet to be isolated, their requirement has been 
demonstrated. First, cloned mammalian TFIID which supports basal 
level transcription, is incapable of supporting activation in response
to SP1 or a  GAL4-VP16 fusion protein in cell extracts depleted of 
the TFIID fraction (review Ptashne and Gann, 1990). This is thought 
to be due to the lack of a  component(s) in preparations of cloned 
TFIID that are present in the heterogeneous TFIID fraction. Second, 
two members of the 'dependent* class of transcriptional activators, 
SP1 and E1a (an adenovirus activator bearing no acidic domain) are 
capable of activation in mammalian cells but not in yeast (Ptashne 
and Gann, 1990). This may reflect differences seen in the amino- 
terminus of TFIID. This is supported by the finding that an excess of 
either yeast TFIID or a  truncated Drosophila TFIID lacking the 
N-terminus are incapable of supporting activation in response to 
SP1 or a  GAL4-VP16 heterologous protein; even though basal level 
transcription remains unaltered. However, excess Drosophila TFIID 
has no effect on the ability of SP1 or GAL4-VP16 to promote basal 
level or activated transcription (Ptashne and Gann, 1990; Pugh and 
Tjian, 1990). Presumably, the lack of N-terminal sequences in yeast 
TFIID and the truncated Drosophila TFIID render them incapable of 
responding to the transcriptional activator and any co-activator(s) 
(Ptashne and Gann, 1990; Lewin, 1990).
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Analysis of the structural and functional domains in yeast 
TFIID (Horikoshi et al.1990) show that unlike TFIID from human and 
Drosophila, there is no distinction between the regions responsible 
for DNA binding and basal level transcription. If, as proposed in 
mammalian systems, the N-terminal domain of TFIID is the target 
seen by transcriptional activators, then interactions between yeast 
TFIID and transcriptional activators may occur two ways. First, 
interactions may occur within the 60 amino-terminal residues as 
proposed by Horikoshi et al. (1990). Secondly interactions are 
mediated by co-activators which are capable in part of 
compensating for the amino terminus of mammalian TFIID; which is 
absent in yeast.
The role of CCR4 in the transcriptional regulation of ADH2 may 
be in a  capacity similar to that of a  co-activator. This is supported 
by the finding that CCR4 acts at or near the TATA box of ADH2 (Denis 
and Malvar, 1990). When regions containing all known responsive 
elements which lie upstream of the ADH2 TATA sequence are deleted 
or displaced by insertions, ADH II activity remains sensitive to 
mutations in CCR4 and the CRE alleles. Additionally, of potential
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interest is the similarities seen between the arrangement of the 
amino termini of TFIID from human and Drosophila and that of CCR4. 
The hydrophilic domains of CCR4 (see Figure 12) would presumably 
be exposed and therefore have the capacity for interactions. The 
action of CCR4 at the promoter to elicit full derepression of ADH2 
may be to provide proper interaction between the DNA binding 
transcriptional activator ADR1 (Eisen et al., 1988) and the 
transcriptional machinery. Note that as the temperature sensitive 
phenotype displayed by CCR4 disruptions indicate, it appears only to 
be required for derepression. This may be explained in that while 
contacts made by CCR4 are not required for low derepressed activity 
which is characteristic of a  ccr4 allele (Table 2), its presence at 
elevated temperatures adds to the stability of the transcriptional 
apparatus. This may explain why disruptions of and mutations 
isolated in CCR4 display the same phenotype. Additional support for 
the requirement of CCR4 in promoting full derepression is seen in 
analysis of the constitutive mutation ADR1-5C. Strains carrying 
ADR1 -5C show elevated ADH II activity on fermentative and 
nonfermentative media (Table 2). Mutations in CCR4 lower
derepressed ADH II activity in an ADR1-5C background 20 fold (Denis, 
1984) yet do not effect fermentative values.
The action imparted by CCR4 can be viewed as an auxiliary 
rather than an essential component of transcription. This is 
analogous to the argument made by Martin et al. (1990) on the role of 
adaptors in E1 a  transcriptional regulation. E1a, unlike acidic 
activators, is dependent on additional uncharacterized factor(s) or 
adaptors. Their argument is based on experiments using heterologous 
constructs bearing the GAL4 DNA binding region and various acidic 
activating domains. The ability of these constuctions to promote 
activation is sensitive to excess levels of VP16, a strong acidic 
activator, but not to excess E1a. In contrast, a  LexA-E1 a fusion 
protein was found to be sensitive to an excess of either VP16 or E1a. 
Martin et al. (1990) reason that the same target (presumably TFIID) 
is contacted in either case but that in the case of E1a an adaptor is 
required for proper contact. The adaptor, therefore, cannot be an 
essential component of the transcriptional machinery.
What role do the CRE alleles play in the epistasis seen between 
them and CCR4? As described above, the amount of CCR4 protein
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remains unchanged when cells are grown fermentatively; a  condition 
not requiring ADH2 activation. The presence of CCR4 protein is not 
surprising since both the CRE alleles and CCR4 have been shown to 
effect multiple loci (Denis, 1984; Denis and Malvar, 1990).
Additionally, Taylor and Young (1990) have shown that ADR1 is bound 
to the UAS1 of ADH2 irrespective of carbon source. Therefore a  
mechanism must exist which inhibits the action of CCR4 at the ADH2 
locus under conditions such as fermentative growth. The CRE 
proteins may act to inhibit the action of CCR4 by binding directly to 
CCR4 or act indirectly by blocking contacts made by CCR4.
More recent findings on the action of SPT6 fCRE21 by Swanson 
et al. (1990) suggest additional means by which CCR4 may regulate 
transcription. The pleiotropic effects described for CCR4 and the 
CRE alleles (Denis, 1984; Denis and Malvar, 1990) may be a result of 
the general effect they have on chromatin structure. This view is 
also supported by the proposed site of action of CCR4 and CRE 
alleles noted above in which they may exert their effect on 
chromatin structure near the TATA box. Swanson et al (1990) find 
that SPT6 codes for a nuclear localized 170-kDal protein that is
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extremely acidic in its amino terminus (residues 1 - 484 have a net 
charge of -81). Proteins containing highly charged regions are 
implicated in chromatin binding (Earnshaw, 1987). Additionally, 
increased or decreased dosage of SPT6 suppress his4-9l2delta 
mutations (Clark-Adams and Winston, 1987) and deletions in the 
regulatory region of the SUC2 locus (Neigeborn et al., 1987. Similar 
effects are seen at the his4-912delta locus in histone gene dosage 
experiments (Clark-Adams et al., 1988). As noted above for strains 
carrying multi-copy plasmids bearing the CCR4 gene, growth was 
noticably slower. The effects of changes in the dosage of these 
alleles suggests that any complexes formed between their products 
is dependent on their stoichiometry. The possibility that CCR4 acts 
through protein interactions implicated by the leucine rich repeats 
is supported by the report that SPT6 contains sequences similar to 
the leucine zipper motif shown to mediate protein : protein 
interactions (Swanson et al. 1990).
The lethality caused by a null allele of SPT6 would suggest its 
essential role in chromatin structure. This is in contrast to the 
observation that all mutations and disruptions in CCR4 are
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temperature sensitive only on nonfermentative media. If CCR4 is 
involved in chromatin stucture then these observations would again 
imply an auxiliary rather that an essential role as discussed above.
Transcription at the ADH2 locus under derepressed conditions 
described by Denis (1984) is dependent on 1) the release from 
glucose repression and 2) the state of the two regulatory circuits in 
which ADR1 and CCR1 comprise one circuit and CCR4 and the CRE 
alleles consitute the second. The manner in which the glucose signal 
is transmitted within the cell is not known. The findings presented 
in this study show no direct evidence of protein interactions 
involving CCR4 and the transcriptional control of the ADH2 locus.
The ideas presented are intended to propose interactions between 
the circuits based on predictions inferred from the mutational 
studies and sequence data generated for CCR4. The two views 
presented on the proposed action of CCR4 and the CRE alleles are not 
necessarily mutually exclusive. While studies indicate that these 
alleles exert their effects near the TATA box, they may act through 
different sequences. The ability of CCR4 to function in an activating 
capacity may be dependent on the chromatin structure as influenced
8 3
by the CRE proteins. Much work remains in order to acertain the role 
that CCR4 plays in transcription. Answers to questions concerning 
protein interactions mediated by CCR4 most likely will follow 
purification of the protein. Additional mutational work on CCR4 is 
needed to further characterize functional domains within the 
protein. Likewise, mutational studies in the promoter region of ADH2 
are needed to further define sequences required for the action of 
CCR4 and the CRE alleles.
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Appendix A 
DNA fragment excision from agarose pels
1. DNA was visualized under UV light after staining with ethidium 
bromide (Maniatis et.al.)
2. The appropriate band was excised from the gel and placed into a 
microfuge tube containing 200 microliters of water.
3. The gel fragment was mashed in the tube using either a  pestal or a 
thin pointed spatula.
4. An equal volume of phenol (equilibrated with TE pH 7.5) was added.
5. The tube was vortexed at high speed for 3 minutes and rapidly 
placed in a  dry ice/ethanol bath for 2 minutes.
6. The phases were separated by a  20 minute high speed spin in a 
microfuge and the upper phase collected to a new tube.
7.1/50 volume of a 5M NaCI solution and 2 volumes of cold ethanol 
was added and the DNA precipitated at -20 0 C for 2 hours or longer.
8. The DNA was collected by centrifugation, drying under a  vacuum, 
and resuspension in sterile water.
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Appendix B
Double straDded-template preparation and alkali denaturation
1. Grow a  2 ml culture of the bacterial clone overnight.
2. Pellet 1.5 ml of the bacteria in a  microfuge for 1 minute and 
remove media by aspiration.
3. Resuspend pellet in 0.21 ml of STET (8% glucose, 0.5% Triton 
X-100, 50 mM EDTA, 10 mM Tris-CI pH 8.0).
4. Add 15 microliters of fresh lysozyme (10 mg/ml in TE 8.0) and 
vortex.
5. Place tube in boiling water bath for 50 seconds and immediately 
centrifuge at RT for 6 minutes.
6. Transfer supernatant to a  new tube and add 1/10 volume of 3 M 
NaOAc and 1 volume of isopropanol.
7. Place on ice for 10 minutes, centrifuge, wash with 70% ethanol, 
dry, and resuspend in 30 microliters of TE.
8. To denature the DNA prior to sequencing; 8 microliters of the DNA, 
6 microliters of 1 N NaOH, and water to 24 microliters w as added to
a microfuge tube.
9. The tube was allowed to stand at RT for 5 minutes and then 3 
microliters of cold ammonium acetate (2 M, pH 4.5) and 70 
microliters of cold ethanol was added.
10. The DNA was precipitated as above, resuspended in 7 microliters 
of water and 2 microliters of Sequenase reaction buffer. 1 
microliter of the appropriate primer was added and sequenced as 
described by the manufacturer.
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